Scientific article
French

Prise en charde du carcinome hépatocellulaire en 2010

Published in

Revue médicale suisse, vol. 6, no. 233, p. 198-202

Publication date

2010

Abstract

Hepatocellular carcinoma (HCC) is one of the most frequent malignant tumors worldwide and its incidence has increased over the last years in most developed countries. The majority of HCCs occur in the context of liver cirrhosis. Therefore, patients with cirrhosis and those with hepatitis B virus infection should enter a surveillance program. Detection of a focal liver lesion by ultrasound should be followed by further investigations to confirm the diagnosis and to permit staging. A number of curative and palliative treatment options are available today. The choice of treatment will depend on the tumor stage, liver function and the presence of portal hypertension as well as the general condition of the patient. A multidisciplinary approach is mandatory to offer to each patient the best treatment.

Keywords

  • Carcinoma, Hepatocellular/epidemiology/pathology/therapy
  • Chemoembolization, Therapeutic
  • Humans
  • Liver Neoplasms/epidemiology/pathology/therapy
  • Liver Transplantation
  • Risk Factors

Citation (ISO format)

PACHE, Isabelle et al. Prise en charde du carcinome hépatocellulaire en 2010. In: Revue médicale suisse, 2010, vol. 6, n° 233, p. 198–202.

Main files (1)

Article (Published version)

Identifiers

Additional URL for this publication

http://rms.medhyg.ch/numero-233-page-198.htm

Journal ISSN

1660-9379
551views
1downloads

Technical informations

Creation

17/10/2013 14:57:00

First validation

17/10/2013 14:57:00

Update

14/03/2023 20:34:02

Status update

14/03/2023 20:34:01

Last indexation

30/10/2024 14:44:54
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated